info@glycoselect.com
Menu
Home
About Us
About Us
Management
Scientific Advisory Board
Careers
Products
Applications
News
Blog
Contact Us
EIIS
Blog
Development of Simple, Rapid & High-Throughput Glycoanalytics for Biopharmaceuticals
June 2022
Simplifying Glycoanalysis with Recombinant Prokaryotic Lectins
April 2022
Streamline Purification of Glycosylated Proteins with Recombinant Prokaryotic Lectins
December 2021
Targeting key glycoproteins: Glucose oxidase
August 2021
Glycoproteins and disease
May 2021
Collaborating on new tools for glycosylation analysis
February 2021
Use of Recombinant Prokaryotic Lectins (RPLs) for Coronavirus Research
April 2020
RPLs for high-throughput analysis of biopharmaceuticals
December 2019
Glycosylation & Glycans
September 2019
June 2022
Development of Simple, Rapid & High-Throughput Glycoanalytics for Biopharmaceuticals
April 2022
Simplifying Glycoanalysis with Recombinant Prokaryotic Lectins
December 2021
Streamline Purification of Glycosylated Proteins with Recombinant Prokaryotic Lectins
August 2021
Targeting key glycoproteins: Glucose oxidase
May 2021
Glycoproteins and disease
February 2021
Collaborating on new tools for glycosylation analysis
April 2020
Use of Recombinant Prokaryotic Lectins (RPLs) for Coronavirus Research
December 2019
RPLs for high-throughput analysis of biopharmaceuticals
September 2019
Glycosylation & Glycans
GlycoSeLect News Stories
GlycoSeLect signs distribution agreement with MJS BioLynx Inc.
GlycoSeLect enters strategic agreement with DBA Italia
New webinar on glycoanalytics features GlycoSeLect
GlycoSeLect sees strong interest in 2021 EIIS Investment Opportunity
GlycoSeLect announces collaboration with OSB Life Sciences
GlycoSeLect at the Washington, DC Virtual Trade Mission with Ireland
Menu
This website uses cookies to improve your experience. If you continue to use this site, you agree with it.
Privacy Policy
Ok
